As Losses Narrow, Is Zai Lab Finally Finding its Winning Formula?
The biotech breaks a cycle of widening losses as it shifts towards developing new drugs Key Takeaways: Zai Lab reported its loss shrank 65% in the first quarter of the…
licensing payments
